The full report suite on the global market for cardiac rhythm management, electrophysiology & cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, implantable loop recorders (ILRs), electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.

In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the

The full report suite on the global market for cardiac ablation catheters includes radiofrequency (RF) ablation catheters and cryoablation catheters.

The full report suite on the global market for diagnostic electrophysiology (EP) catheters includes conventional electrophysiology catheters, advanced electrophysiology catheters and intracardiac echocardiography (ICE) catheters.

The full report suite on the global market for electrophysiology (EP) lab system includes 3D mapping systems and electrophysiology (EP) recording systems.

Overall, the global implantable loop recorder market was valued at over $1.3 billion in 2021. This is expected to increase over the forecast period at a CAGR of 7.9% to reach nearly $2.3 billion.

The full report suite on the global market for cardiac resynchronization therapy (CRT) devices includes cardiac resynchronization therapy-pacemakers (CRT-Ps) and cardiac resynchronization therapy-defibrillators (CRT-Ds).

The full report suite on the global market for cardiac resynchronization therapy (CRT) devices includes cardiac resynchronization therapy-pacemakers (CRT-Ps) and cardiac resynchronization therapy-defibrillators (CRT-Ds).

The full report suite on the global market for pacemakers includes single-chamber pacemakers, dual-chamber pacemakers and leadless pacemakers.

This global market research includes conventional EP catheters and advanced EP catheters analyzed as a combined market segment. The analysis also covers radiofrequency (RF) cardiac ablation catheters and cryoablation catheters.

The total market for Europe’s cardiac rhythm management devices market is growing at a rate of 3.9%, which will take the 2018 market value of €2.2 billion up to €2.9 billion by 2025. Reprocessed diagnostic electrophysiology (EP) catheters accounted for a significant percentage of all diagnostic EP catheters used. Reprocessed catheters have a much lower

The full report suite on the global market for cardiac leads includes cardiac leads, pacing leads, defibrillation leads and left ventricle (LV) leads.